This newslink doesn't exist or it was removed.
Go to Homempage.
Forbes USA Tech January 19, 2023
A gymnast grabs two rings - one in each hand.univsport.com The current generation of monoclonal antibodies is ineffective against the predominant variants of SARS-CoV-2 in circulation. Recent studies by Callaway et al. open the possibility that a new type of monoclonal antibody... + más
The Bivalent Booster Protects Against New COVID-19 Variants, New Data Show | Time
FDA Experts Vote to Make All COVID-19 Vaccines and Boosters Bivalent | Time
Time USA Health November 10, 2022
New lab data suggest that vaccines and prior infections may not offer enough protection against several new COVID-19 variants cropping up in the U.S. and around the world. Dr. David Ho, director of Columbia University’s Aaron Diamond AIDS Research Center (ADARC), and his team... + más
How Concerned Should You Be About Covid-19 ‘Scrabble' Variants? | NBC 6 South Florida
Quick and stealthy 'Scrabble variants' are poised to drive a winter Covid-19 surge | CNN
The Boston Globe USA Nation December 29, 2022
A new coronavirus variant dubbed XBB has swiftly spreading in the Northeast, jumping from about 35 percent of cases during the week ending Dec. 17 to just over half of cases last week, according to .Here’s a quick primer on what we know about the variant.It is more... + más
Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly | CNBC
RTTNews USA Health May 03, 2023
Elanco Animal Health Inc. announced that the U.S. Department of Agriculture or USDA has issued a conditional license for its Canine Parvovirus Monoclonal Antibody.The company expects to begin shipping Canine Parvovirus Monoclonal Antibody in the coming weeks, pending individual... + más
USDA releases $71 million in grants in pursuit of ‘equality and justice for all’ | Fox News
'Frustration' fuels Broncos' sideline blowup in loss | ESPN
Time USA Health January 27, 2023
AstraZeneca Plc’s COVID antibody drug is no longer authorized for use in the U.S., regulators said Thursday, as it’s unlikely to work against strains of the virus that are now dominant across the country. Astra’s drug, called Evusheld, was authorized in December 2021 to... + más
FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants | ABC News
FDA halts authorization of Evusheld, citing medication insufficient against viral COVID-19 variants | ABC7
About iurex | Privacy Policy | Disclaimer |